↓ Skip to main content

PLOS

Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues

Overview of attention for article published in PLOS ONE, December 2008
Altmetric Badge

Mentioned by

patent
2 patents
f1000
1 research highlight platform

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
117 Mendeley
connotea
1 Connotea
Title
Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues
Published in
PLOS ONE, December 2008
DOI 10.1371/journal.pone.0003922
Pubmed ID
Authors

Eduardo K. Moioli, Paul A. Clark, Mo Chen, James E. Dennis, Helaman P. Erickson, Stanton L. Gerson, Jeremy J. Mao

Abstract

Poor angiogenesis is a major road block for tissue repair. The regeneration of virtually all tissues is limited by angiogenesis, given the diffusion of nutrients, oxygen, and waste products is limited to a few hundred micrometers. We postulated that co-transplantation of hematopoietic and mesenchymal stem/progenitor cells improves angiogenesis of tissue repair and hence the outcome of regeneration. In this study, we tested this hypothesis by using bone as a model whose regeneration is impaired unless it is vascularized. Hematopoietic stem/progenitor cells (HSCs) and mesenchymal stem/progenitor cells (MSCs) were isolated from each of three healthy human bone marrow samples and reconstituted in a porous scaffold. MSCs were seeded in micropores of 3D calcium phosphate (CP) scaffolds, followed by infusion of gel-suspended CD34(+) hematopoietic cells. Co-transplantation of CD34(+) HSCs and CD34(-) MSCs in microporous CP scaffolds subcutaneously in the dorsum of immunocompromised mice yielded vascularized tissue. The average vascular number of co-transplanted CD34(+) and MSC scaffolds was substantially greater than MSC transplantation alone. Human osteocalcin was expressed in the micropores of CP scaffolds and was significantly increased upon co-transplantation of MSCs and CD34(+) cells. Human nuclear staining revealed the engraftment of transplanted human cells in vascular endothelium upon co-transplantation of MSCs and CD34(+) cells. Based on additional in vitro results of endothelial differentiation of CD34(+) cells by vascular endothelial growth factor (VEGF), we adsorbed VEGF with co-transplanted CD34(+) and MSCs in the microporous CP scaffolds in vivo, and discovered that vascular number and diameter further increased, likely owing to the promotion of endothelial differentiation of CD34(+) cells by VEGF. Together, co-transplantation of hematopoietic and mesenchymal stem/progenitor cells may improve the regeneration of vascular dependent tissues such as bone, adipose, muscle and dermal grafts, and may have implications in the regeneration of internal organs.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Switzerland 1 <1%
Germany 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 111 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 26%
Researcher 23 20%
Student > Master 17 15%
Professor > Associate Professor 10 9%
Professor 9 8%
Other 22 19%
Unknown 6 5%
Readers by discipline Count As %
Medicine and Dentistry 33 28%
Agricultural and Biological Sciences 32 27%
Engineering 15 13%
Biochemistry, Genetics and Molecular Biology 9 8%
Materials Science 6 5%
Other 10 9%
Unknown 12 10%